F1000Research F1000Research 2046-1402 F1000 Research Limited London, UK 10.12688/f1000research.10280.1 Review Articles Developmental Molecular Mechanisms Medical Genetics Morphogenesis & Cell Biology Muscle & Connective Tissue Musculoskeletal Repair & Regeneration Stem Cells & Regeneration Insight into skin cell-based osteogenesis: a review

[version 1; peer review: 2 approved]

 Wang Tingliang https://orcid.org/0000-0001-7440-7119 1 2 Zhu Lian 2 Pei Ming https://orcid.org/0000-0001-5710-3578 a 1 3 4 Stem Cell and Tissue Engineering Laboratory, Department of Orthopaedics, West Virginia University, Morgantown, WV, USA Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China Division of Exercise Physiology, West Virginia University, Morgantown, WV, USA Mary Babb Randolph Cancer Center, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, WV, USA mpei@hsc.wvu.edu

Competing interests: The authors declare that they have no competing interests.

 17 3 2017 2017 6 F1000 Faculty Rev-291 14 3 2017 Copyright: © 2017 Wang T et al. 2017 This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

For decades, researchers have been fascinated by the strategy of using cell therapy for bone defects; some progress in the field has been made. Owing to its ample supply and easy access, skin, the largest organ in the body, has gained attention as a potential source of stem cells. Despite extensive applications in skin and nerve regeneration, an increasing number of reports indicate its potential use in bone tissue engineering and regeneration. Unfortunately, few review articles are available to outline current research efforts in skin-based osteogenesis. This review first summarizes the latest findings on stem cells or progenitors in skin and their niches and then discusses the strategies of skin cell-based osteogenesis. We hope this article elucidates this topic and generates new ideas for future studies.

 stem cell therapy skin cells osteogenesis Musculoskeletal Transplant Foundation National Institutes of Health 1R01AR067747-01A1and1R03AR062763-01A1 This work was supported by research grants from the Musculoskeletal Transplant Foundation and the National Institutes of Health (1R03AR062763-01A1 and 1R01AR067747-01A1). Editorial Note on the Review Process

F1000 Faculty Reviews are commissioned from members of the prestigious F1000 Faculty and are edited as a service to readers. In order to make these reviews as comprehensive and accessible as possible, the referees provide input before publication and only the final, revised version is published. The referees who approved the final version are listed with their names and affiliations but without their reports on earlier versions (any comments will already have been addressed in the published version).

The referees who approved this article are:

Gordana Vunjak-Novakovic, Columbia University, New York, USA

No competing interests were disclosed.

Zulma Gazit, Cedars-Sinai Medical Center, Los Angeles, CA, USA

No competing interests were disclosed.

 Introduction

Finding appropriate therapeutic cells for bone regeneration has been a challenge for decades. Recently, stem cells from the skin, a potentially large cell source with easy access, have caught the attention of clinicians and scientists. More and more evidence indicates that skin stem cells are a potential cell source for bone regeneration. For example, heterozygous inactivating mutations of GNAS (encoding guanine nucleotide-binding G protein alpha subunit) cause diseases, including progressive osseous heteroplasia, Albright hereditary osteodystrophy, pseudohypoparathyroidism, and osteoma cutis 1– 4 . These disorders have the common features of superficial ossification, starting with cutaneous ossification, with some involving subcutaneous and deeper tissues and some restricted to the skin. Multipotent progenitor cells and bone morphogenetic proteins (BMPs) were reported to be responsible for ectopic ossification 5, 6 .

Despite a decade of investigations using skin stem cells for regenerative medicine, most literature concerns their application in skin tissue engineering 7 and nerve regeneration 8 , which was well covered by a recent review article 9 . However, few review articles are available on skin cell-based osteogenesis. This review first summarizes the latest findings on stem cells or progenitors in skin and their niches and then discusses the strategies of skin cell-based osteogenesis ( Figure 1). We hope this article elucidates this topic and generates new ideas for future studies.

Skin cells for osteogenesis.

(A–G) Stem cells and niches found in skin. (A) Hair follicle bulge-derived stem cells 11, 12, 15 . (B) Hair follicle papilla-derived stem cells 18, 22– 24 . (C) Hair sheath-derived stem cells 16, 22 . (D) Pericytes 10, 51 . (E) Sweat gland-derived stem cells 25, 26 . (F) Interfollicle epidermis-derived stem cells 13, 14 . (G) Stem cells from dermal niches that are not fully characterized 27– 34, 50, 52, 53 . (H–K) Strategies for using skin cells. (H) Total skin fibroblasts 35, 36 . (I) Genetic modification 38– 48 . (J) Cell sorting 33, 50– 53 . (K) Cell reprogramming 56– 58, 65 . (L–O) Skin cells’ osteogenesis. (L) Limb bone defect regeneration 35, 41, 42 . (M) Cranial bone defect regeneration 38, 43, 44, 53 . (N) Mandibular bone defect regeneration 40, 48 . (O) Rib bone defect regeneration 45 .

 Characteristics of skin stem cells and niches

Besides the primary structure of the epidermis, dermis, and subcutaneous tissue, there are hair follicles, vessels, capillaries, neurons, sweat glands, sebaceous glands, lymphatic capillaries, and erector pili muscles in skin, implying that there could be numerous niches for stem cells and progenitors in this tissue ( Table 1). Evidence also indicates that stem cells in skin, so-called pericytes, might be of perivascular origin 10 .

Characterization of skin stem cells and niches.
Location Niche Culture Name Markers Differentiation potential References
Epidermis Interfollicle epidermis Adherence Epidermal stem cells α6 integrin, β1 integrins, CD133, CD90, and keratin 15 Keratinocytes 13, 14
Hair follicle and appendages Hair follicle bulge Adherence Keratinocyte stem cells/ epidermal neural crest stem cells Keratin 15, keratin 19, β1 integrins, CD200, PHLDA1, follistatin, frizzled homolog 1, CD24 lo, CD34 lo, CD71 lo, and CD146 lo Keratinocytes, all major neural crest lineages, including neurons, Schwann cells, myofibroblasts, melanocytes, and bone/ cartilage cells 11, 12, 14, 15
Hair follicle sheath Floating spheres Dermal sheath cells Nestin, fibronectin, CD34, and keratin 15(−) Adipogenic and osteogenic lineages 16, 22
Hair follicle papillae Floating spheres Skin-derived precursor cells βIII-tubulin, p75NTR, NF-M; CNPase, GFAP, and S100β Adipogenic, osteogenic, chondrogenic, and myogenic lineages, neurons, glia, and Schwann cells 18– 23
Sweat gland Adherence Sweat gland stroma- derived stem cells α6 integrin and nestin Adipogenic, chondrogenic, and osteogenic lineages 25, 26
Dermis Perivascular Adherence Pericytes CD146, NG2, CD31(−), CD34(−), CD144(−), and VWF(−) Adipogenic, chondrogenic, myogenic, and osteogenic lineages 10, 51
Undefined niches of dermis Adherence Dermal stem cells/dermis- derived stromal cells CD13, CD29, CD44, CD49d, CD71, CD73, CD90, CD105, CD166, SSEA4, vimentin, CD14(−), CD31(−), CD34(−), CD45(−), CD106(−), CD133(−), SSEA3(−), and nestin(−) Adipogenic, chondrogenic, myogenic, and osteogenic lineages 27– 34, 50, 52, 53

CNPase, 2′,3′-cyclic nucleotide 3′-phosphodiesterase; GFAP, glial fibrillary acidic protein; NG2, neural/glial antigen 2; PHLDA1, pleckstrin homology-like domain family A member 1; SSEA4, stage-specific embryonic antigen-4; VWF, von Willebrand factor.

 Epidermis

Epidermal stem cells are found in both hair follicle bulge 11, 12 and interfollicular epidermis 13, 14 . They are also viewed as keratinocyte stem cells because they generate cells that produce keratin 11, 14 . Recent reports indicate that human epidermal stem cells are able to create all major neural crest derivatives containing neurons, Schwann cells, myofibroblasts, melanocytes, and bone/cartilage cells 15, 16 . Despite the investigation of many stem cell markers, such as α6 integrin 5-bromo-2-deoxyuridine, β1 integrins, CD133, CD200, CD90, keratin 15, delta 1, and p63 17 , the molecular signature of epidermal stem cells remains undetermined.

 Hair follicle and appendages

Hair follicles have long been considered an important niche for stem cells because of the versatility in regeneration of hair and epidermis and wound repair. For example, skin-derived precursors (SKPs) from both murine and human origins residing in the papillae of hair follicles 18 can differentiate into neuron, glia, smooth muscle, and adipose cells 19, 20 . As non-adherent cells, the SKPs are cultured as floating spheres with a neural crest origin 21 . Although lineage differentiation crosses both ectoderm and mesoderm 18, 20 , their potential for osteogenesis has seldom been tested, although a cell subpopulation characterized from hair follicle dermal papilla and dermal sheath of both rats and humans has the capacity for adipogenesis, myogenesis, chondrogenesis, and osteogenesis 22– 24 . In addition, since keratinocytes can be generated from the hair follicle bulge, the hair follicle is an important niche for epidermal stem cells 11, 12 . These findings indicate that the hair follicle is one of the most important niches in skin with stem cells and progenitors generating mesenchymal lineages. Recent studies indicate that sweat glands, a skin appendage, are also characterized as a niche for stem cells which can be isolated and induced into three mesodermal lineages 25, 26 .

 Dermis

Dermis constitutes the majority of skin in both thickness and cell number. Dermal fibroblasts, the principal cells in dermis, have long been considered terminally differentiated cells and served as a negative control of mesenchymal stem cells (MSCs). When preserved in saline at 4°C for 6 days before digesting, non-hair follicle human dermis has been successfully proven to be an MSC source, indicative of a potential niche for stem cells 27 . This finding is supported by another report, in which clonal analysis of a single dermal fibroblast isolated from human foreskin exhibited tripotent, bipotent, and unipotent ability 28 , indicating multiple differentiation potential in dermal fibroblasts. Increasing evidence also demonstrates that these cells are positive for surface markers CD29, CD44, CD73, CD90, CD105, and CD166, indicating their MSC nature, and negative for CD14, CD31, CD34, CD45, and CD133, indicating non-hematopoietic lineage 29– 34 .

 Strategies for using skin cells for osteogenesis

Fibroblasts from rabbit skin were osteoinduced followed by seeding on porous titanium pylon; this construct exhibited enhanced osseointegrative properties compared with unseeded pylon in both in vitro and in vivo studies 35 . This study and others 36 suggest the possibility of using skin fibroblasts for osteogenesis, although an early report showed the inhibition of rat skin fibroblasts on mineralization of bone marrow MSCs 37 . Unfortunately, owing to the low osteogenic potential of total skin fibroblasts with mixed cell populations, this kind of trial is far from successful. Therefore, it is critical to isolate skin cells with a preference for differentiation toward osteogenesis.

Genetic modification

Using modification of genes to increase the expression of specific osteogenesis-related genes, skin fibroblasts, acting as “protein secretors” without differentiating by themselves or having the paracrine/exosomal effects that are found in MSCs, were promoted for bone tissue engineering and regeneration 38– 41 . These genes of interest include BMP-2 41– 45 , BMP-4 42 , BMP-7 38, 42 , Runx2 (runt-related transcription factor 2) 39, 43, 46, 47 , and LMP-3 ( lim mineralization protein-3) 40, 48 . In in vivo studies using skin fibroblasts, both ectopic osteogenesis and orthotopic bone regeneration are achieved through gene therapy 42, 44 from small animals like mice 44 , rats 38, 42, 48 , and rabbits 41 to large animals like equines 45 . A study comparing different genes of interest for modification efficiency of skin fibroblasts determined that BMP-2 is more powerful than Runx2 43 and that the mineralization ability of Runx2-modified skin fibroblasts is scaffold-dependent 39 . Gene therapy is a promising method with a prominent effect; however, the safety of viral genetic modification needs further characterization 49 .

 Cell sorting

Mixed populations isolated from total skin make cell therapy strategies for osteogenesis unsuccessful. Consequently, there are increasing efforts in sorting cells from skin to get target subpopulations. For example, type IV collagen-coated dishes have been used to attract CD29(+) human dermal stem cells via adherence, which exhibited higher osteogenic, adipogenic, and chondrogenic capacity compared with unsorted cells 33 . CD271(+) and CD146(+) cells isolated from human skin and CD73(−)CD105(+) cells isolated from mouse skin by immunosorting also showed elevated multi-differentiation potential 50– 52 . Interestingly, subpopulations sorted by other markers from human skin, such as CD73, stage-specific embryonic antigen-4 (SSEA-4), and BmprIB, show relatively restricted differentiation potential. For instance, BmprIB(+) cells can generate only an osteogenic lineage 50, 53 , indicating that these subpopulations can be applied as therapeutic cells for osteogenesis because of their established lineage preference. However, concern due to low harvest rate resulting from cell sorting still exists 50, 51, 53 .

 Cell reprogramming

Characterized by unlimited proliferation and differentiation potential like embryonic stem cells 54, 55 , induced pluripotent stem cells (iPSCs) can be used in numerous stem cell therapies. As skin fibroblasts are the most abundant and easily accessed cells, they are commonly chosen as the parent cells of iPSCs. It has been well characterized that iPSC-derived osteoblasts can form osteoid both in vitro and in vivo 56– 58 . A recent study revealed that bone defect repair is also achieved by human iPSCs in a radial defect model of immune-deficient mice 59 . Furthermore, the involvement and mechanism of microRNAs in the regulation of mouse iPSCs during osteogenic differentiation have been preliminarily investigated 60 .

 Conclusions and perspectives

In past decades, investigations using skin cells for osteogenesis have achieved significant progress. Many niches for stem cells in skin have been revealed and preliminarily characterized. Also, skin cells, enriched or not enriched, modified or not modified, are used for osteogenesis in vitro and in vivo and have achieved success in limb, cranial, mandibular, and rib bone defect regeneration ( Figure 1). However, some key problems remain unsolved. For example, since the niche for stem cells in dermis is not completely characterized, the efficiency of enriching stem cells or progenitors from skin is still restricted. For cell modification strategies, like gene therapy and cell reprogramming, the efficacy might be readily apparent, but the safety needs more in-depth research.

Recent developments in epigenetic conversion may shed some light on cell reprogramming. Unlike in iPSCs, epigenetic conversion does not completely reverse cells to the pluripotent stem cell stage 61– 64 . This approach may avoid undesired side effects such as teratoma, which often occurs in the application of iPSCs and embryonic stem cells. Epigenetic conversion has achieved progress in directing fibroblasts from human skin and mouse embryos into cardiomyocytes, neuronal cells, and insulin-secreting cells with a mature phenotype 61, 63, 64 . Although not much is known about converting skin fibroblasts into osteoblasts, there is a report of converting non-osteogenic cells into osteoblasts by epigenetic stimulation of BMP-2 expression 65 . By transient use of platelet-derived growth factor-AB and 5-azacytidine, mature bone and fat cells can also be converted into multipotent stem cells 62 . Thus, although there are no studies characterizing the cells converted for bone regeneration, the most common candidate for epigenetic conversion, skin cells, may play a significant role in this strategy.

Taken together, two of these strategies are promising. One strategy is the enrichment of stem cells and progenitors from different skin niches. By improving the current low-efficiency cell isolation, a mass of therapeutic cells can be gathered from skin for better bone tissue engineering and regeneration. The other strategy is based on the easy access and abundant amount of skin fibroblasts. Via modification of the cell, either through iPSCs or the recent concept of epigenetic conversion, a differentiation-specific cell population can be manipulated and gathered. In that case, therapeutic cells for osteogenesis can be harvested on a large scale, making both the autologous and allogeneic approaches possible.

 Acknowledgments

We thank Suzanne Danley for editing the manuscript.

 Kaplan FS Craver R MacEwen GD : Progressive osseous heteroplasia: a distinct developmental disorder of heterotopic ossification. Two new case reports and follow-up of three previously reported cases. J Bone Joint Surg Am. 1994;76(3):425–36. 8126048 10.2106/00004623-199403000-00013 Adegbite NS Xu M Kaplan FS : Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS-based heterotopic ossification. Am J Med Genet A. 2008;146A(14):1788–96. 18553568 10.1002/ajmg.a.32346 2564798

F1000 Recommendation

Shore EM Kaplan FS : Inherited human diseases of heterotopic bone formation. Nat Rev Rheumatol. 2010;6(9):518–27. 20703219 10.1038/nrrheum.2010.122 3551620 Myllylä RM Haapasaari KM Palatsi R : Multiple miliary osteoma cutis is a distinct disease entity: four case reports and review of the literature. Br J Dermatol. 2011;164(3):544–52. 21062265 10.1111/j.1365-2133.2010.10121.x Wosczyna MN Biswas AA Cogswell CA : Multipotent progenitors resident in the skeletal muscle interstitium exhibit robust BMP-dependent osteogenic activity and mediate heterotopic ossification. J Bone Miner Res. 2012;27(5):1004–17. 22307978 10.1002/jbmr.1562 3361573

F1000 Recommendation

Myllylä RM Haapasaari K Lehenkari P : Bone morphogenetic proteins 4 and 2/7 induce osteogenic differentiation of mouse skin derived fibroblast and dermal papilla cells. Cell Tissue Res. 2014;355(2):463–70. 24253465 10.1007/s00441-013-1745-0

F1000 Recommendation

Kamel RA Ong JF Eriksson E : Tissue engineering of skin. J Am Coll Surg. 2013;217(3):533–55. 23816384 10.1016/j.jamcollsurg.2013.03.027 Chen Z Pradhan S Liu C : Skin-derived precursors as a source of progenitors for cutaneous nerve regeneration. Stem Cells. 2012;30(10):2261–70. 22851518 10.1002/stem.1186 3448815 Vapniarsky N Arzi B Hu JC : Concise Review: Human Dermis as an Autologous Source of Stem Cells for Tissue Engineering and Regenerative Medicine. Stem Cells Transl Med. 2015;4(10):1187–98. 26253713 10.5966/sctm.2015-0084 4572907 Crisan M Yap S Casteilla L : A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell. 2008;3(3):301–13. 18786417 10.1016/j.stem.2008.07.003

F1000 Recommendation

Lyle S Christofidou-Solomidou M Liu Y : The C8/144B monoclonal antibody recognizes cytokeratin 15 and defines the location of human hair follicle stem cells. J Cell Sci. 1998;111(Pt 21):3179–88. 9763512 Ohyama M Terunuma A Tock CL : Characterization and isolation of stem cell-enriched human hair follicle bulge cells. J Clin Invest. 2006;116(1):249–60. 16395407 10.1172/JCI26043 1323261 Ghazizadeh S Taichman LB : Multiple classes of stem cells in cutaneous epithelium: a lineage analysis of adult mouse skin. EMBO J. 2001;20(6):1215–22. 11250888 10.1093/emboj/20.6.1215 145528 Ito M Liu Y Yang Z : Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis. Nat Med. 2005;11(12):1351–4. 16288281 10.1038/nm1328

F1000 Recommendation

Clewes O Narytnyk A Gillinder KR : Human epidermal neural crest stem cells (hEPI-NCSC)--characterization and directed differentiation into osteocytes and melanocytes. Stem Cell Rev. 2011;7(4):799–814. 21455606 10.1007/s12015-011-9255-5 3252033 Kanno H Kubo A Yoshizumi T : Isolation of multipotent nestin-expressing stem cells derived from the epidermis of elderly humans and TAT-VHL peptide-mediated neuronal differentiation of these cells. Int J Mol Sci. 2013;14(5):9604–17. 23644888 10.3390/ijms14059604 3676801 Ghadially R : 25 years of epidermal stem cell research. J Invest Dermatol. 2012;132(3 Pt 2):797–810. 22205306 10.1038/jid.2011.434 3998762 Fernandes KJ McKenzie IA Mill P : A dermal niche for multipotent adult skin-derived precursor cells. Nat Cell Biol. 2004;6(11):1082–93. 15517002 10.1038/ncb1181

F1000 Recommendation

Toma JG Akhavan M Fernandes KJ : Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol. 2001;3(9):778–84. 11533656 10.1038/ncb0901-778 Toma JG McKenzie IA Bagli D : Isolation and characterization of multipotent skin-derived precursors from human skin. Stem Cells. 2005;23(6):727–37. 15917469 10.1634/stemcells.2004-0134 Biernaskie JA McKenzie IA Toma JG : Isolation of skin-derived precursors (SKPs) and differentiation and enrichment of their Schwann cell progeny. Nat Protoc. 2006;1(6):2803–12. 17406538 10.1038/nprot.2006.422 Jahoda CA Whitehouse J Reynolds AJ : Hair follicle dermal cells differentiate into adipogenic and osteogenic lineages. Exp Dermatol. 2003;12(6):849–59. 14714566 10.1111/j.0906-6705.2003.00161.x Hoogduijn MJ Gorjup E Genever PG : Comparative characterization of hair follicle dermal stem cells and bone marrow mesenchymal stem cells. Stem Cells Dev. 2006;15(1):49–60. 16522162 10.1089/scd.2006.15.49 Bajpai VK Mistriotis P Andreadis ST : Clonal multipotency and effect of long-term in vitro expansion on differentiation potential of human hair follicle derived mesenchymal stem cells. Stem Cell Res. 2012;8(1):74–84. 22099022 10.1016/j.scr.2011.07.003 3222855 Lu CP Polak L Rocha AS : Identification of stem cell populations in sweat glands and ducts reveals roles in homeostasis and wound repair. Cell. 2012;150(1):136–50. 22770217 10.1016/j.cell.2012.04.045 3423199 Nagel S Rohr F Weber C : Multipotent nestin-positive stem cells reside in the stroma of human eccrine and apocrine sweat glands and can be propagated robustly in vitro. PLoS One. 2013;8(10):e78365. 24205211 10.1371/journal.pone.0078365 3813437

F1000 Recommendation

Bartsch G Yoo JJ De Coppi P : Propagation, expansion, and multilineage differentiation of human somatic stem cells from dermal progenitors. Stem Cells Dev. 2005;14(3):337–48. 15969629 10.1089/scd.2005.14.337 Chen FG Zhang WJ Bi D : Clonal analysis of nestin - vimentin + multipotent fibroblasts isolated from human dermis. J Cell Sci. 2007;120(Pt 16):2875–83. 17652163 10.1242/jcs.03478 Jääger K Islam S Zajac P : RNA-seq analysis reveals different dynamics of differentiation of human dermis- and adipose-derived stromal stem cells. PLoS One. 2012;7(6):e38833. 22723894 10.1371/journal.pone.0038833 3378616 Crigler L Kazhanie A Yoon TJ : Isolation of a mesenchymal cell population from murine dermis that contains progenitors of multiple cell lineages. FASEB J. 2007;21(9):2050–63. 17384147 10.1096/fj.06-5880com 2034200 Lorenz K Sicker M Schmelzer E : Multilineage differentiation potential of human dermal skin-derived fibroblasts. Exp Dermatol. 2008;17(11):925–32. 18557932 10.1111/j.1600-0625.2008.00724.x

F1000 Recommendation

Huang HI Chen SK Ling QD : Multilineage differentiation potential of fibroblast-like stromal cells derived from human skin. Tissue Eng Part A. 2010;16(5):1491–501. 20001268 10.1089/ten.TEA.2009.0431 Shim JH Kang HH Lee TR : Enrichment and characterization of human dermal stem/progenitor cells using collagen type IV. J Dermatol Sci. 2012;67(3):202–5. 22784784 10.1016/j.jdermsci.2012.06.007 Hill RP Gledhill K Gardner A : Generation and characterization of multipotent stem cells from established dermal cultures. PLoS One. 2012;7(11):e50742. 23226372 10.1371/journal.pone.0050742 3511366 Shevtsov MA Galibin OV Yudintceva NM : Two-stage implantation of the skin- and bone-integrated pylon seeded with autologous fibroblasts induced into osteoblast differentiation for direct skeletal attachment of limb prostheses. J Biomed Mater Res A. 2014;102(9):3033–48. 24115308 10.1002/jbm.a.34969 3969869

F1000 Recommendation

Hee CK Jonikas MA Nicoll SB : Influence of three-dimensional scaffold on the expression of osteogenic differentiation markers by human dermal fibroblasts. Biomaterials. 2006;27(6):875–84. 16102817 10.1016/j.biomaterials.2005.07.004 Ogiso B Hughes FJ Melcher AH : Fibroblasts inhibit mineralised bone nodule formation by rat bone marrow stromal cells in vitro. J Cell Physiol. 1991;146(3):442–50. 2022698 10.1002/jcp.1041460315 Krebsbach PH Gu K Franceschi RT : Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo. Hum Gene Ther. 2000;11(8):1201–10. 10834621 10.1089/10430340050015248 Phillips JE Hutmacher DW Guldberg RE : Mineralization capacity of Runx2/Cbfa1-genetically engineered fibroblasts is scaffold dependent. Biomaterials. 2006;27(32):5535–45. 16857257 10.1016/j.biomaterials.2006.06.019 Lattanzi W Parrilla C Fetoni A : Ex vivo-transduced autologous skin fibroblasts expressing human Lim mineralization protein-3 efficiently form new bone in animal models. Gene Ther. 2008;15(19):1330–43. 18633445 10.1038/gt.2008.116 3488859 Ishihara A Weisbrode SE Bertone AL : Autologous implantation of BMP2-expressing dermal fibroblasts to improve bone mineral density and architecture in rabbit long bones. J Orthop Res. 2015;33(10):1455–65. 25418909 10.1002/jor.22791 4441610

F1000 Recommendation

Rutherford RB Moalli M Franceschi RT : Bone morphogenetic protein-transduced human fibroblasts convert to osteoblasts and form bone in vivo. Tissue Eng. 2002;8(3):441–52. 12167230 10.1089/107632702760184709 Hirata K Tsukazaki T Kadowaki A : Transplantation of skin fibroblasts expressing BMP-2 promotes bone repair more effectively than those expressing Runx2. Bone. 2003;32(5):502–12. 12753866 10.1016/S8756-3282(03)00054-1 Wang R Zou Y Yuan Z : Autografts and xenografts of skin fibroblasts delivering BMP-2 effectively promote orthotopic and ectopic osteogenesis. Anat Rec (Hoboken). 2009;292(6):777–86. 19462444 10.1002/ar.20904 Ishihara A Zekas LJ Weisbrode SE : Comparative efficacy of dermal fibroblast-mediated and direct adenoviral bone morphogenetic protein-2 gene therapy for bone regeneration in an equine rib model. Gene Ther. 2010;17(6):733–44. 20220786 10.1038/gt.2010.13 Phillips JE Guldberg RE Garcia AJ : Dermal fibroblasts genetically modified to express Runx2/Cbfa1 as a mineralizing cell source for bone tissue engineering. Tissue Eng. 2007;13(8):2029–40. 17516856 10.1089/ten.2006.0041 Phillips JE García AJ : Retroviral-mediated gene therapy for the differentiation of primary cells into a mineralizing osteoblastic phenotype. Methods Mol Biol. 2008;433:333–54. 18679633 10.1007/978-1-59745-237-3_20 Parrilla C Lattanzi W Rita Fetoni A : Ex vivo gene therapy using autologous dermal fibroblasts expressing hLMP3 for rat mandibular bone regeneration. Head Neck. 2010;32(3):310–8. 19626643 10.1002/hed.21185 Zwaka TP : Use of genetically modified stem cells in experimental gene therapies.In: Templeton NS (Eds.). Gene and Cell Therapy: Therapeutic Mechanisms and Strategies, third edition. Taylor & Francis/CRC Press, Boca Raton, FL.2009;731–6. 10.1201/9780849387999.ch34 Vaculik C Schuster C Bauer W : Human dermis harbors distinct mesenchymal stromal cell subsets. J Invest Dermatol. 2012;132(3 Pt 2):563–74. 22048731 10.1038/jid.2011.355 3278768

F1000 Recommendation

Ruetze M Knauer T Gallinat S : A novel niche for skin derived precursors in non-follicular skin. J Dermatol Sci. 2013;69(2):132–9. 23148930 10.1016/j.jdermsci.2012.10.007

F1000 Recommendation

Lee SB Shim S Kim MJ : Identification of a distinct subpopulation of fibroblasts from murine dermis: CD73 - CD105 + as potential marker of dermal fibroblasts subset with multipotency. Cell Biol Int. 2016;40(9):1008–16. 27170595 10.1002/cbin.10623

F1000 Recommendation

Wang T He J Zhang Y : A Selective Cell Population From Dermis Strengthens Bone Regeneration. Stem Cells Transl Med. 2016; pii: sctm.2015-0426. 27502515 10.5966/sctm.2015-0426 Takahashi K Yamanaka S : Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663–76. 16904174 10.1016/j.cell.2006.07.024

F1000 Recommendation

Takahashi K Tanabe K Ohnuki M : Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861–72. 18035408 10.1016/j.cell.2007.11.019

F1000 Recommendation

Bilousova G Jun du H King KB : Osteoblasts derived from induced pluripotent stem cells form calcified structures in scaffolds both in vitro and in vivo. Stem Cells. 2011;29(2):206–16. 21732479 10.1002/stem.566 3321731 Jin GZ Kim TH Kim JH : Bone tissue engineering of induced pluripotent stem cells cultured with macrochanneled polymer scaffold. J Biomed Mater Res A. 2013;101(5):1283–91. 23065721 10.1002/jbm.a.34425

F1000 Recommendation

Lou X : Induced Pluripotent Stem Cells as a new Strategy for Osteogenesis and Bone Regeneration. Stem Cell Rev. 2015;11(4):645–51. 26022504 10.1007/s12015-015-9594-8 Sheyn D Ben-David S Shapiro G : Human Induced Pluripotent Stem Cells Differentiate Into Functional Mesenchymal Stem Cells and Repair Bone Defects. Stem Cells Transl Med. 2016;5(11):1447–60. 27400789 10.5966/sctm.2015-0311 5070500

F1000 Recommendation

Okamoto H Matsumi Y Hoshikawa Y : Involvement of microRNAs in regulation of osteoblastic differentiation in mouse induced pluripotent stem cells. PLoS One. 2012;7(8):e43800. 22937097 10.1371/journal.pone.0043800 3427148 Brevini TA Pennarossa G Maffei S : Epigenetic Conversion as a Safe and Simple Method to Obtain Insulin-secreting Cells from Adult Skin Fibroblasts. J Vis Exp. 2016; (109):e53880. 27023000 10.3791/53880

F1000 Recommendation

Chandrakanthan V Yeola A Kwan JC : PDGF-AB and 5-Azacytidine induce conversion of somatic cells into tissue-regenerative multipotent stem cells. Proc Natl Acad Sci U S A. 2016;113(16).E2306–15. 27044077 10.1073/pnas.1518244113 4843430

F1000 Recommendation

Cao N Huang Y Zheng J : Conversion of human fibroblasts into functional cardiomyocytes by small molecules. Science. 2016;352(6290):1216–20. 27127239 10.1126/science.aaf1502

F1000 Recommendation

Black JB Adler AF Wang HG : Targeted Epigenetic Remodeling of Endogenous Loci by CRISPR/Cas9-Based Transcriptional Activators Directly Converts Fibroblasts to Neuronal Cells. Cell Stem Cell. 2016;19(3):406–14. 27524438 10.1016/j.stem.2016.07.001 5010447

F1000 Recommendation

Cho YD Yoon WJ Kim WJ : Epigenetic modifications and canonical wingless/int-1 class (WNT) signaling enable trans-differentiation of nonosteogenic cells into osteoblasts. J Biol Chem. 2014;289(29):20120–8. 24867947 10.1074/jbc.M114.558064 4106327

F1000 Recommendation